Key result
Blockade of the renin-angiotensin system has a distinct advantage in preventing the progression of chronic renal insufficiency to complete renal failure.
Why the study?
Does blockade of the renin-angiotensin system prevent the progression of chronic renal disease to complete renal failure?
Does blockade of the renin-angiotensin system prevent the progression of chronic renal disease to complete renal failure?
Answers are grounded in this paper and cite their sources.
Blockade of the renin-angiotensin system is advantageous in preventing the progression of chronic renal disease to end-stage renal failure.
End-stage renal disease (ESRD) is a costly and debilitating condition affecting 250,000 patients in the United States. The incidence of ESRD has doubled in the past 10 years and is expected to continue to increase well into the next century as our population ages. Over the past 20 years investigative efforts have been focused on defining the pathophysiological basis of chronic renal disease and on therapeutic interventions designed to prevent its progression to renal failure. Several experimental models of progressive renal disease have been developed and used to examine potential mechanisms which may contribute to the pathophysiology of renal failure. Data from these studies indicate that the renin-angiotensin system (RAS) contributes significantly to the pathophysiology of renal disease in the experimental models examined. Data from clinical studies also indicates that the RAS contributes to the progression of renal disease in man as well. While our knowledge in this area is far from complete, numerous experimental and clinical studies have demonstrated that the blockade of the RAS has a distinct advantage in preventing the progression of renal insufficiency to complete renal failure.
No takes yet. Share an insight, caveat, or question.
Kivlighn et al. (1997) conducted a review in Chronic renal disease and end-stage renal disease (ESRD). Blockade of the renin-angiotensin system (RAS) was evaluated on Progression of renal insufficiency to complete renal failure. Blockade of the renin-angiotensin system has a distinct advantage in preventing the progression of chronic renal insufficiency to complete renal failure.
Synapse has enriched 10 related papers. Consider them for comparative context: